Central African Republic vs Niger: Share of people with HIV who receive antiretroviral therapy
Central African Republic
66.0%
in 2024
Niger
66.0%
in 2024
Central African Republic rank
87th
Niger rank
87th
Share of people with HIV who receive antiretroviral therapy over time
- Central African Republic
- Niger
How they compare
Central African Republic currently reports 66.0% against 66.0% in Niger, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Niger ahead.
Central African Republic ranks 87th and Niger ranks 87th of 143 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.4% | 3.6% | 1.2% | Niger |
| 2010s | 23.8% | 40.2% | 16.4% | Niger |
| 2020s | 58.6% | 67.6% | 9.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Central African Republic or Niger?
- Central African Republic, at 66.0% against 66.0% in Niger as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Central African Republic and Niger?
- 0.0%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Central African Republic and Niger rank globally for share of people with hiv who receive antiretroviral therapy?
- Central African Republic ranks 87th and Niger ranks 87th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.